Tonix Pharmaceuticals (NASDAQ: TNXP) reported Q4 EPS of ($0.83), $0.02 worse than the analyst estimate of ($0.81).

For earnings history and earnings-related data on Tonix Pharmaceuticals (TNXP) click here.